BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19423012)

  • 1. (18)F-labelled metomidate analogues as adrenocortical imaging agents.
    Erlandsson M; Karimi F; Lindhe O; Långström B
    Nucl Med Biol; 2009 May; 36(4):435-45. PubMed ID: 19423012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of [
    Bongarzone S; Basagni F; Sementa T; Singh N; Gakpetor C; Faugeras V; Bordoloi J; Gee AD
    Nucl Med Biol; 2019; 68-69():14-21. PubMed ID: 30578137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.
    Bergström M; Bonasera TA; Lu L; Bergström E; Backlin C; Juhlin C; Långström B
    J Nucl Med; 1998 Jun; 39(6):982-9. PubMed ID: 9627330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues.
    Zolle IM; Berger ML; Hammerschmidt F; Hahner S; Schirbel A; Peric-Simov B
    J Med Chem; 2008 Apr; 51(7):2244-53. PubMed ID: 18348518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Para-chloro-2-[
    Silins I; Sundin A; Nordeman P; Jahan M; Estrada S; Monazzam A; Lubberink M; Aigbirhio F; Hellman P; Antoni G
    Int J Med Sci; 2021; 18(10):2187-2196. PubMed ID: 33859526
    [No Abstract]   [Full Text] [Related]  

  • 6. Syntheses of F-18 labeled fluoroalkyltyrosine derivatives and their biological evaluation in rat bearing 9L tumor.
    Moon BS; Lee TS; Lee KC; An GI; Cheon GJ; Lim SM; Choi CW; Chi DY; Chun KS
    Bioorg Med Chem Lett; 2007 Jan; 17(1):200-4. PubMed ID: 17035015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully automated radiosynthesis of [1-(2-[18 F]fluoroethyl),1H[1,2,3]triazole 4-ethylene] triphenylphosphonium bromide as a potential positron emission tomography tracer for imaging apoptosis.
    Haslop A; Gee A; Plisson C; Long N
    J Labelled Comp Radiopharm; 2013 May; 56(6):313-6. PubMed ID: 24285410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro evaluation of [18F]FETO with respect to the adrenocortical and GABAergic system in rats.
    Mitterhauser M; Wadsak W; Wabnegger L; Sieghart W; Viernstein H; Kletter K; Dudczak R
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1398-401. PubMed ID: 12845489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of microwave-based automated nucleophilic [(18)F]fluorination system and its application to the production of [(18)F]flumazenil.
    Mandap KS; Ido T; Kiyono Y; Kobayashi M; Lohith TG; Mori T; Kasamatsu S; Kudo T; Okazawa H; Fujibayashi Y
    Nucl Med Biol; 2009 May; 36(4):403-9. PubMed ID: 19423008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-step, "one-pot" radiosynthesis of 6-fluoro-3,4-dihydroxy-L-phenylalanine by isotopic exchange.
    Wagner FM; Ermert J; Coenen HH
    J Nucl Med; 2009 Oct; 50(10):1724-9. PubMed ID: 19759110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A one-step automated high-radiochemical-yield synthesis of 18F-FECNT from mesylate precursor.
    Chen ZP; Wang SP; Li XM; Liu CY; Tang J; Cao GX; Luo SN; Zhang LF; Jin J
    Appl Radiat Isot; 2008 Dec; 66(12):1881-5. PubMed ID: 18571931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
    Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic preparation of [18F]FE@SUPPY and [18F]FE@SUPPY:2--comparison with conventional radiosyntheses.
    Ungersboeck J; Philippe C; Mien LK; Haeusler D; Shanab K; Lanzenberger R; Spreitzer H; Keppler BK; Dudczak R; Kletter K; Mitterhauser M; Wadsak W
    Nucl Med Biol; 2011 Apr; 38(3):427-34. PubMed ID: 21492791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 2-[(18)F]fluoroethylazide for the Staudinger ligation - Preparation and characterisation of GABA(A) receptor binding 4-quinolones.
    Gaeta A; Woodcraft J; Plant S; Goggi J; Jones P; Battle M; Trigg W; Luthra SK; Glaser M
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4649-52. PubMed ID: 20579877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of novel F-18 labeled fluoroarylvaline derivatives: potential PET imaging agents for tumor detection.
    Qiao Y; He Y; Zhang S; Li G; Liu H; Xu J; Wang X; Qi C; Peng C
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4873-7. PubMed ID: 19616943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.
    McGrath M; Ma C; Raines DE
    J Pharmacol Exp Ther; 2018 Feb; 364(2):229-237. PubMed ID: 29203576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microwave-assisted concise total syntheses of quinazolinobenzodiazepine alkaloids.
    Liu JF; Kaselj M; Isome Y; Chapnick J; Zhang B; Bi G; Yohannes D; Yu L; Baldino CM
    J Org Chem; 2005 Dec; 70(25):10488-93. PubMed ID: 16323862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(3)H]metyrapol and 4-[(131)i]iodometomidate label overlapping, but not identical, binding sites on rat adrenal membranes.
    Berger ML; Hammerschmidt F; Qian R; Hahner S; Schirbel A; Stichelberger M; Schibli R; Yu J; Arion VB; Woschek A; Öhler E; Zolle IM
    Mol Pharm; 2013 Mar; 10(3):1119-30. PubMed ID: 23343186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary in vivo and ex vivo evaluation of the 5-HT2A imaging probe [(18)F]MH.MZ.
    Herth MM; Piel M; Debus F; Schmitt U; Lüddens H; Rösch F
    Nucl Med Biol; 2009 May; 36(4):447-54. PubMed ID: 19423013
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.